As methods and disciplines merge, the ability to regenerate cardiac tissue is a goal with incalculable benefits from benchtop to bedside. Cellbased therapy in cardiac regeneration circulation. Our goal was to improve cardiac function after myocardial infarction through hesbased cardiovascular tissue engineering. Biomaterial approaches for stem cellbased myocardial tissue. Current status of induced pluripotent stem cells in. Future challenges of stem cell based cardiac tissue engineering. In this backstory, cell stem cell senior scientific editor jonathan saxe presents a case study of two cell stem cell papers published in 2018. Stem cellbased cardiovascular tissue engineering infoscience.
Additionally, stem cellbased strategies, consisting of cell transplantation and cardiac tissue engineering, will be addressed to compare their features and limitations. The limited proliferation ability of host cardiac cells has motivated investigators to research the potential cardiac regenerative ability of stem cells. Pdf stem cellbased cardiovascular tissue engineering. Engineered biomaterials also have applications in cardiac tissue engineering, in which tissue constructs are developed in vitro by combining stem cells and. Adult stem cells for cardiac tissue engineering sciencedirect.
Bone marrowderived stem cells mesenchymal stem cells. Stem cellbased cardiac tissue engineering springerlink. Stem cellbased therapy through genome editing techniques can repair gene mutation, control better maturation of cms or even reveal its. Tissue engineering strategies aim at developing efficient therapeutic approaches to overcome the current challenges in prolonging patients survival upon cardiac diseases. Bioactive scaffolds in stemcellbased therapies for.
Tissue engineers must have a thorough understanding of the cues that guide multiple cell types to form functional tissue. Cardiac repair in guinea pigs with human engineered heart. Reduction of adverse cardiac scarring facilitates pluripotent stem cellbased therapy for myocardial infarction jialiang liang,a wei huang,a lin jiang,a christian paul,a xiangnan li,a,b yigang wanga key words. Cardiac tissue engineering and regeneration using cellbased.
Cardiac tissue engineering an overview sciencedirect topics. The cardiac tissue is then replaced with nonfunctional fibrotic scar tissue rather than new cardiac cells, which leaves the heart weak. Engineered biomaterials also have applications in cardiac tissue engineering, in which tissue constructs are developed in vitro by combining stem cells and biomaterial scaffolds for drug screening. Stem cellderived cell sheetbased cardiac tissue engineering has already shown more beneficial effects in mi than direct injection or the administration of stem cells with 3d scaffolds. Stem cellbased tissue replacement after stroke stroke. Stem cells used for cardiovascular tissue engineering.
Additionally, stem cell based strategies, consisting of cell transplantation and cardiac tissue engineering, will be addressed to compare their features and limitations. Normal wound healing is a dynamic and complex multiple phase process involving coordinated interactions between growth factors, cytokines, chemokines, and various cells. Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cellderived cardiovascular cells. As a new generational cellbased regenerative therapy, tissue engineering is focused. Stem cell therapy and tissue engineering represent a forefront of current research in the treatment of heart disease. Stem cellbased cardiac tissue engineering, journal of. To this aim, cells with a differentiation potential towards vascular. Engineered biomaterials to enhance stem cellbased cardiac. Engineered biomaterials also have applications in cardiac tissue engineering, in which tissue constructs are developed in vitro by combining stem cells and biomaterial scaffolds for drug screening or eventual implantation.
This book covers stateoftheart knowledge on the potential of stem cells for the regeneration of a wide range of tissues and organs. Most cellbased grafts are unviable because of inadequate perfusion. Pdf cardiovascular diseases are the leading cause of death worldwide, and cellbased therapies represent a potential cure for patients with cardiac. Full text cardiac tissue engineering and regeneration. The production of a functional cardiac tissue to be transplanted in the injured area of the infarcted myocardium represents a challenge for regenerative medicine. Current status of induced pluripotent stem cells in cardiac. The impact of stem cell technology on tissue engineering will be revolutionary. Stem cell research and tissue engineering have become leading fields in basic research worldwide. Recently, mscbased tissue engineering studies for heart disease have shown encouraging findings, but translation to the clinical setting is still required. As the field of cardiac tissue regeneration develops novel protocols for stem cellbased therapies, visualizations that didactically convey in vitro spatiotemporal cellcell interactions become increasingly important to.
Human induced pluripotent stem cell derived cardiomyocytes hipsccms. With these technologies, advancements are being made into therapies for acute ischemic myocardial injury and chronic, otherwise nonreversible, myocardial failure. Here we report a novel and scalable method to generate scaffoldfree human cardiac tissue patches. Our laboratory has originally developed cell sheetbased scaffoldfree tissue. Stem cell therapy has provided first proofofconcept, thus paving the way to tissue engineering to fabricate cellularized valves endowed with anticoagulative properties and living cardiac tissue that grows physiologically in parallel with the heart s growth. The development of new biomaterials for tissue engineering provides a scientific basis. Biomaterialfree threedimensional bioprinting of cardiac. However, stem cellbased tissue replacement may be aggravated by pathophysiological and anatomic. Our goal was to improve cardiac function after myocardial infarction through hes based cardiovascular tissue engineering. May 14, 2015 stem cell therapy and tissue engineering represent a forefront of current research in the treatment of heart disease. Many tissue engineering interventions certainly have potential, and new stem cell techniques are poised to help advance these treatments into the scope of cardiovascular nursing. Types of stem cell for cardiac therapy by definition, stem cells are undifferentiated cells that are clonogenic, selfrenewing, and pluripotent or multi potent.
Cardiac tissue engineering and regeneration using cellbased therapy mohammad t alrefai, divya murali,4 arghya paul,4 khalid m ridwan,1,2 john m connell,1,2 dominique shumtim1,2 1division of cardiac surgery, 2division of surgical research, mcgill university health center, montreal, qc, canada. Cells are thought to operate either directly, by replacing the unhealthy cells in the damaged tissue, or indirectly, via the secretion of molecules and microvesicles that stimulate endogenous mecha. Toward this end, stem cells, including cardiac stem cells cscs 20, embryonic stem cells 21, bone marrowderived mesenchymal stem cells 22, and cordderived mesenchymal stem cells 23 are essential materials for cellbased tissue engineering applica. Any failure in these phases may lead wounds to become chronic and have abnormal scar formation. Cardiac cellbased therapies aim to overcome the limitations of gene therapy via the adoptive transfer of healthy cells, rather than isolated genes. The cell based therapies are performed by using the injection of dissociated cells, scaffold based tissue engineering, and cell sheet based tissue engineering.
Tissue engineering of the heart the journal of thoracic and. The failure of the neuroprotective paradigm and limited eligibility for thrombolysis spawned an interest in stem cellbased neurorestoration, 6 which is characterized by a wide therapeutic window and is highly convergent with rehabilitation. Review article strategies affording prevascularized cell. Since adult cardiac cells are limited in their proliferation, cardiac tissue with dead or damaged cardiac cells downstream of the occluded vessel does not regenerate after myocardial infarction. Cardiac tissue engineering and regeneration using cellbased therapy. Regenerative therapies using cell sheetbased tissue. Cardiac tissue engineering aims to develop functional acellular or cellular tissue constructs that can efficiently repair and regenerate the infarcted myocardium to resume its native form and function. The main approach of cardiac tissue engineering is to create cardiac grafts, either. Nanotechnologybased stem cell tissue engineering with a. For stem cells to be used in tissue engineering a scaffold is essential to provide the necessary support for the transport of nutrients, oxygen and the elimination of metabolic waste, promoting a conducive environment for cell growth and differentiation. Especially in cardiovascular medicine, initial reports on the potential of using stem cells to recover cardiac function and replace organ subunits such as heart valves seemed to offer the promise of widespread clinical use in the near future.
Pluripotent stem cells fibrosis cell therapy tissue stiffness cardiomyocytes. Introduction one of the most ambitious objectives for cardiac tissue engineering aimed at repairing an infarcted cardiac region is the production of a stem cellbased functional tissue that. Cardiac cell based therapies aim to overcome the limitations of gene therapy via the adoptive transfer of healthy cells, rather than isolated genes. Current phase iii clinical trials and possible nearfuture tissue engineering trials implementing mscs for cardiac repair will turn the page to the next chapter of heart disease treatments.
Chronic wounds affect patients quality of life, since they require repetitive treatments and incur considerable medical costs. Using this model, the authors identify two hit compounds that restart cardiomyocyte proliferation by synergistically activating the mevalonate pathway and cell. Nov 23, 2019 kharaziha m, memic a, akbari m, brafman da, nikkhah m 2016 nanoenabled approaches for stem cellbased cardiac tissue engineering. Towards this goal, cardiac tissue engineering is now being investigated as an approach to support cell based therapies and enhance their efficacy. Cardiac tissue engineering an overview sciencedirect. These properties are met in polyurethanebased scaffoldsfigure 2, and. Based on this knowledge and potential, human embryonic stem cells. Scaffoldfree human cardiac tissue patch created from. Tissue engineering approaches to regenerate myocardium involve transplantation of cells andor biomaterial scaffolds to the infarcted area. Human embryonic stem cells were differentiated to cardiomyocytes using activin a and bmp4 and placed into suspension on a rotating orbital shaker. Stem cell therapy and tissue engineering for correction of.
Nanoenabled approaches for stem cell based cardiac tissue engineering 19 may 2016 advanced healthcare materials, vol. We will present an overview of the central approaches focusing on pluripotent stem cellderived cells, mechanisms of action, autologous vs. Future challenges of stemcellbased cardiac tissue engineering. The cellbased therapies are performed by using the injection of dissociated cells, scaffoldbased tissue engineering, and cell sheetbased tissue engineering. Tissue engineering in a classical sense implies the use of organspecific cells for seeding a scaffold ex vivo. Stem cellderived cell sheet transplantation for heart.
Considerable progress has been made in this endeavor. Cardiac tissue engineering and regeneration using cell. At present, cardiac diseases are a major cause of morbidity and mortality in the world. As the field of cardiac tissue regeneration develops novel protocols for stem cell based therapies, visualizations that didactically convey in vitro spatiotemporal cell cell interactions become increasingly important to. Mesenchymal stem cellbased therapy for cardiovascular. The cardiac tissue is then replaced with nonfunctional fibrotic scar tissue rather than new. Nanoenabled approaches for stem cellbased cardiac tissue engineering 19 may 2016 advanced healthcare materials, vol. Primarily a wide range of biomaterials, along with different types of stem cells, which have utilized in cardiac tissue engineering will be. Toward this end, stem cells, including cardiac stem cells cscs, embryonic stem cells, bone marrowderived mesenchymal stem cells, and cordderived mesenchymal stem cells are essential materials for cell based tissue engineering applications. To better construct functional 3d cell sheetbased cardiac tissues, multiplelayer up to 12 layers cardiac cell sheet can be produced on a vascular bed to. Stem cellderived cell sheet transplantation for heart tissue.
Recently, a cellbased regenerative medicine has appeared as one of the most potential and promising therapies for improving cardiac diseases. Future challenges of stem cellbased cardiac tissue engineering. The recent advancement of stem cell biology provides enormous opportunities to engineer stem cells for tissue engineering. To better construct functional 3d cell sheet based cardiac tissues, multiplelayer up to 12 layers cardiac cell sheet can be produced on a vascular bed to. Cells aggregated to form macroscopic discshaped patches of beating tissue after 2 days. For example, ex vivo tissue engineering approaches, whereby human cardiomyogenic cells are combined with mesenchymal stem cells mscs, vasculogenic cells 42, 60, 405, andor neurons 224, 389 may be required prior to engraftment, for meaningful cardiac regeneration. We have developed a novel method to deliver stem cells using 3d bioprinted cardiac patches, free of biomaterials. Towards this goal, cardiac tissue engineering is now being investigated as an approach to support cellbased therapies and enhance their efficacy.
It may not be necessary or desirable to culture a noncardiogenic tissue patch in vitro for extended time periods before implantation, whereas the use of cardiogenic cells to create tissue patches with structure and function resembling those of native cardiac muscle will require specialized and wellcontrolled culture conditions. Strategies affording prevascularized cellbased constructs. Biomaterial approaches for stem cellbased myocardial. Furthermore, cardiac stem cell based tissue engineering approaches could also be designed to stimulate cardiac resident non stem cells that may also release factors such as vegf and hgf that may also act in an autocrine and paracrine fashion to modulate antiapoptotic, antiremodeling and angiogenic responses. Challenges in cardiac tissue engineering tissue engineering. The application of escs in cardiac tissue regeneration and engineering could be tracked back to 2002. Jul 12, 2011 cardiovascular diseases are the leading cause of death worldwide, and cell based therapies represent a potential cure for patients with cardiac diseases such as myocardial infarction, heart failure, and congenital heart diseases.
Application of injectable hydrogels for cardiac stem cell. Most cell based grafts are unviable because of inadequate perfusion. Key results of allogeneic and autologous stem cell trials are presented, including the use of embryonic, bone marrowderived, adiposederived, and resident cardiac stem cells. Tissueengineered regeneration of a failing human heart remains a major chal lenge, while. From the laboratory for stem cells and tissue engineering, columbia university. The integration of advanced biomaterials and stem cells has offered enormous promises for regeneration of damaged myocardium. Stem cell sources such as adult stem cells, embryonic and induced pluripotent stem cells have been the focal point of research in cardiac tissue engineering. Reduction of adverse cardiac scarring facilitates pluripotent. Additionally, it has been shown that when delivered to the in vivo heart tissue, these scaffolds have the potential to promote stem cell differentiation, cardiac regeneration, and angiogenesis. Tissue engineering aims to the generation of 3d cardiac tissue with a. The cellbased but not necessarily stem cellbased nature of tissue engineering served to define it, and to distinguish it from guided tissue regeneration in which a scaffold is designed to. Stem cell derived cell sheet based cardiac tissue engineering has already shown more beneficial effects in mi than direct injection or the administration of stem cells with 3d scaffolds.
718 672 984 260 1322 494 1414 1248 1318 1407 1147 1326 959 1128 1539 1063 537 568 104 148 1334 692 929 1461 449 1048 1192 1147 1241 424 47 661